COVID-19 Pandemic Impacts Decision-Making and Psychosocial Behavior in Women Seeking Fertility Treatment in APAC—an ASPIRE Patient Experience Report
Budi Wiweko1,*, Tuong M. Ho2, Atsushi Tanaka3, Vanessa Raggio4, Jung-Ryeol Lee5, Milind Patil6, Carina Chi-Wai Chan7, Teraporn Wutayavanich8, Feiyang Diao9, Suresh Nair10,Rudie Frederick Mendiola11
Background: ASPIRE (Asia-Pacific Initiative on Reproduction) aims to develop a “patient-centered” guide to provide fertility treatment based on patient preferences, needs, and concerns during and beyond the SARS-Cov-2 pandemic.
Methods: Women, aged 20–45 years old, trying to conceive for more than 6 months and contemplating for pregnancy including IVF treatment. A country wise analysis of patient behavior, attitudes and concerns, reasons for disruption of treatment and availability of assistance from fertility clinics during SARS-Cov-2 pandemic was performed. Six problem statements addressing patient concerns were identified and corresponding solutions to improve patient experience were formulated. A two-tier recommendation was developed. Tier 1 comprises recommendations in which the rate of “absolutely agree” responses were 60%, whereas tier 2 refers to recommendations in which the rate of “absolutely agree” plus “agree” together was >60%.
Results: Women in countries that have better infection control and are living a new normal were less worried about the pandemic influencing their lifestyle and finances. The proportion of women choosing not to continue IVF/IUI treatment during COVID-19 was similar across countries. Sixty-five percent of women in Group A intend to continue treatment during COVID-19 pandemic. Nine out of 10 patients are expected to resume or start treatment once fertility clinics are accessible. A patient-centered guide focusing on management of patient safety concerns, reduction in difficulty of access to hospitals, prioritization of patients, provision of emotional support, and improvement in patient education and acceptance of remote health services was developed.
Conclusion: This ASPIRE patient experience report highlights a patient-centered guide on provision of safe fertility treatment across the Asia-Pacific region, which can be adapted to suit country-specific requirements depending on the stage of the pandemic, local restrictions, and availability of resources.
COVID-19; Pandemic; Assisted Reproductive Technology (ART); Asia Pacific; Decision-Making and Psychosocial Behavior.
Review The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists.
[ Esteves SC1, Alviggi C2, Humaidan P3,4, Fischer R5, Andersen CY6, Conforti A2, Bühler K7,8, Sunkara SK9, Polyzos NP10, Galliano D11, Grynberg M12, Yarali H13, Özbek IY13, Roque M14, Vuong LN15,16, Banker M17, Rienzi L18, Vaiarelli A18, Cimadomo D18, Ubaldi FM18 ]
This article represents a viewpoint on the POSEIDON criteria by a group of clinicians and embryologists. Its primary o...
Review Needle-free jet versus conventional needle injection for local anesthesia in men undergoing surgical sperm retrieval
[ L. D. Khoa1, T. N. Quang2, P. D. Toan1, N. M. T. Loc1, N. T. N. Diem1, V. Q. Dang1, H. N. A. Vu1, B. W. Mol3 and D. J. Handelsman4 ]
Surgical sperm retrieval, requiring local anesthetic injection, is the most frequent surgical procedur...
Review Endocrine requirements for oocyte maturation following hCG, GnRH agonist, and Kisspeptin during IVF treatment
[ Ali Abbara 1, Tia Hunjan 1, Vu N. A. Ho 2, Sophie A. Clarke 1, Alexander N. Comninos 1, Chioma Izzi-Engbeaya 1, Tuong M. Ho 2, Geoffrey H. Trew 3, Artsiom Hramyka 4, Tom Kelsey 4, Rehan Salim 3, Peter Humaidan 5, Lan N. Vuong 2,6 and Waljit S. Dhillo 1 ]
Objective: The maturation of oocytes to acq...
Review Gonadotropin-Releasing Hormone Agonist Versus Human Chorionic Gonadotropin for Ovulation Induction in Polycystic Ovary Syndrome Patients Undergoing Intrauterine Insemination: A Randomised Controlled Trial
[ Anh N. Ha1,*, Toan D. Pham1,2, Vinh Q. Dang1,2, Lan N. Vuong1,3, Tuong M. Ho1,2 ]
Gonadotropins have been recommended to improve ovula...
Review Large randomized controlled trials in infertility
[ Rui Wang, M.D., Ph.D.a, Zi-Jiang Chen, M.D., Ph.D.b,c,d, Lan N. Vuong, M.D., Ph.D.e, Richard S. Legro, M.D.f, Ben W. Mol, M.D., Ph.D.a and Jack Wilkinson, Ph.D.g ]
As the first paper in this series of Views and Reviews on randomized controlled trials (RCTs), we aim to provide the b...